YusufSWittesJProbstfieldJ. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA1991; 266: 93–98.
2.
RobinsJM.The control of confounding by intermediate variables. Stat Med1989; 8: 679–701.
3.
MurrayEHernánM. Adherence adjustment in the Coronary Drug Project: a call for better per-protocol effect estimates in randomized trials. Clin Trials2016; 13: 372-378.
4.
Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med1980; 303: 1038–1041.